JP Morgan's Anupam Rama raised their price target on BridgeBio Pharma (NASDAQ: BBIO) by 28.6% from $35 to $45 on March 20, 2024. The analyst maintained their Strong Buy rating on the stock.According ...
Source LinkJP Morgan's Anupam Rama raised their price target on BridgeBio Pharma (NASDAQ: BBIO) by 28.6% from $35 to $45 on March 20, 2024. The analyst maintained their Strong Buy rating on the stock.According ...
Source Link
Comments